TREATMENT OF REFRACTORY GENERALIZED STATUS EPILEPTICUS WITH CONTINUOUS-INFUSION OF MIDAZOLAM

被引:91
作者
PARENT, JM
LOWENSTEIN, DH
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,EPILEPSY RES LAB,SAN FRANCISCO,CA 94143
关键词
D O I
10.1212/WNL.44.10.1837
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The optimal therapeutic approach for the patient with refractory generalized status epilepticus remains to be defined. We describe four patients with refractory generalized status epilepticus who were successfully treated with intravenous midazolam. Each patient had prolonged convulsive status epilepticus unresponsive to standard doses of intravenous benzodiazepines, phenytoin, and phenobarbital. The patients subsequently received midazolam administered as an intravenous bolus (200 mu g/kg) followed by a continuous infusion (0.75 to 11 mu g/kg/min) lasting 8 hours to 10 days. Clinical examination and scalp electroencephalographic monitoring documented the cessation of seizure activity within minutes of the loading dose in all patients. No significant adverse effects occurred during midazolam treatment. The one patient with prolonged midazolam infusion required fluid boluses and pressors for moderate hypotension, and the remainder of the patients safely tolerated midazolam despite preexistent hemodynamic instability. All patients recovered and maintained good seizure control. Intravenous midazolam appears to be an effective treatment for refractory generalized status epilepticus, and may represent a substantial improvement over current therapeutic approaches such as pentobarbital anesthesia.
引用
收藏
页码:1837 / 1840
页数:4
相关论文
共 23 条
[1]   ADVANCES IN THE MANAGEMENT OF REFRACTORY STATUS EPILEPTICUS [J].
BLECK, TP .
CRITICAL CARE MEDICINE, 1993, 21 (07) :955-957
[2]   ACCUMULATION OF MIDAZOLAM AFTER REPEATED DOSAGE IN PATIENTS RECEIVING MECHANICAL VENTILATION IN AN INTENSIVE-CARE UNIT [J].
BYATT, CM ;
LEWIS, LD ;
DAWLING, S ;
COCHRANE, GM .
BRITISH MEDICAL JOURNAL, 1984, 289 (6448) :799-800
[3]  
BYRNE AJ, 1984, BRIT MED J, V289, P1309, DOI 10.1136/bmj.289.6454.1309
[4]  
CRISP CB, 1988, CLIN PHARMACY, V7, P322
[5]   CURRENT CONCEPTS IN NEUROLOGY - MANAGEMENT OF STATUS EPILEPTICUS [J].
DELGADOESCUETA, AV ;
WASTERLAIN, C ;
TREIMAN, DM ;
PORTER, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (22) :1337-1340
[6]  
DOMINO EF, 1987, NEUROTOXICOLOGY, V8, P113
[7]   MIDAZOLAM - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE [J].
DUNDEE, JW ;
HALLIDAY, NJ ;
HARPER, KW ;
BROGDEN, RN .
DRUGS, 1984, 28 (06) :519-543
[8]  
GALVIN GM, 1987, ARCH EMERG MED, V4, P169
[9]   INTRAVENOUS MIDAZOLAM FOR THE TREATMENT OF REFRACTORY STATUS EPILEPTICUS [J].
KUMAR, A ;
BLECK, TP .
CRITICAL CARE MEDICINE, 1992, 20 (04) :483-488
[10]  
Lowenstein DD, 1992, DRUGS CONTROL EPILEP, P513